Effect of Breast Screening Regimen on Breast Cancer Outcomes: A Modeling Study
Current Oncology · 2023
DOI: 10.3390/curroncol30110686 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2023. Verfasst von Martin J Yaffe und 1 weiteren Autor:innen. Beteiligte Einrichtung: Physical Sciences Platform, Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Guidelines vary for the age at which to begin breast cancer screening and the interval between examinations. A validated computer model was used to compare estimated outcomes between various screening regimens. The OncoSim-Breast microsimulation model (Canadian Partnership Against Cancer) was used to simulate a cohort of 1.53 million Canadian women born in 1975. The effect of screening regimen on absolute breast cancer mortality rates, stage at diagnosis, number needed to be screened to avert a breast cancer death or save a life year, abnormal recall rates and negative biopsy rates was examined for unscreened women or those entering screening at age 40 or 50 and screened annually or biennially to age 74. Compared to no screening, absolute mortality reduction was 4.6 (biennial 50–74), 5.9 (biennial 40–74) and 7.9 (annual 40–74) fewer deaths per 1000 women. The absolute rate of diagnosis of advanced cancers (Stage 2, 3 and 4) falls in favor of earlier stages as the number of lifetime screens increases. Annual screening beginning at age 40 until age 74 would provide an additional reduction of 2 and 3.3 breast cancer deaths per 1000 women compared to biennial screening beginning at ages 40 and 50, respectively. There is a corresponding drop in the absolute number of Stage 2, 3 and 4 cancers diagnosed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Physical Sciences Platform, Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.
- Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada.
- Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada.
ORCID-Profile: Martin J Yaffe, James G Mainprize
Zitieren
APA
Yaffe, M. J., & Mainprize, J. G. (2023). Effect of Breast Screening Regimen on Breast Cancer Outcomes: A Modeling Study. Current Oncology. https://doi.org/10.3390/curroncol30110686
Vancouver
Yaffe MJ, Mainprize JG. Effect of Breast Screening Regimen on Breast Cancer Outcomes: A Modeling Study. Current Oncology. 2023. doi:10.3390/curroncol30110686
BibTeX
@article{Yaffe2023,
author = {Yaffe, Martin J and Mainprize, James G},
title = {Effect of Breast Screening Regimen on Breast Cancer Outcomes: A Modeling Study},
journal = {Current Oncology},
year = {2023},
doi = {10.3390/curroncol30110686}
}
EUVIMED